Pharma Microbiology Congress 25 Insights – Focus on Rapid Microbiology Methods (Session 2 & 6)

  • On demand
  • Online
  • Inglese

Contenuto del corso

Following the enthusiastic feedback received from attendees of the three-day event, PEC is pleased to make available a selection of recorded virtual sessions. This initiative aims to give professionals in pharmaceutical microbiology—especially those who could not attend in person—the opportunity to access key discussions and valuable insights shared during the congress.

The Scientific Board has selected the sessions dedicated to Rapid Microbiological Methods (RMM), specifically Sessions 2 and 6, recognizing their high relevance and timeliness. These sessions stand out for the diversity of expert perspectives and practical case studies presented, made possible also through collaboration with Bioforum. They feature contributions from a PEI assessor and include an overview of the latest pharmacopoeial regulatory updates, providing a comprehensive view of current trends and future directions in RMM.

Gain access to these exclusive recordings and stay up to date with the latest developments shaping the future of rapid microbiology.

 

METHODOLOGY: The extract will be delivered via recording. The participant will receive a link to access the platform, where the content will remain available for 2 days from the date of delivery.

Cosa saprai fare dopo il corso?

  • SESSION 2 - Rapid Microbiological Methods (RMMs) are becoming a regulatory expectation and a strategic imperative for sterile manufacturers, representing essential tools for enhancing the Sterility assurance. Authorities like the EMA and FDA are encouraging the adoption of RMMs, provided they are properly validated. The session will explore the RMM’s journey that industries are addressing among regulatory requirements, advanced technologies and culture shift.
  • SESSION 6 - This focus will provide an overview of the regulatory landscape for alternative methods, offering an opportunity to delve into the expectations of authorities for the implementation of these new technologies.
Program

SESSION 2 – INDUSTRY’S JOURNEY TOWARDS RAPID METHODS: PERSPECTIVES AND APPLICATIONS

Introduction by the Chairperson
Alice Le Gatt, Global Change Facilitator | BioPhorum

Industry’s Journey towards Rapid Microbiological Methods: A BioPhorum Perspective
Alice Le Gatt, Global Change Facilitator | BioPhorum
Caitlin Cooke, Scientist, Global Product Development, Pharmaceutical Technology and Development | AstraZeneca

Project Management and Validation Strategy of Growth Direct System for Environmental Monitoring and Water-Bioburden
Miriam Meinersmann, Expert GMP Compliance and Documentation Microbiology and Monitoring Quality Control | Daiichi Sankyo Europe GmbH, Germany
Franziska Graf, Trainee Microbiology and Monitoring Quality Control | Daiichi Sankyo Europe GmbH, Germany

Implementation roadmap of OWBA in Pharma, with use-case of implementing enzyme activity-based OWBA on PW/WFI
Sebastian Strandberg Rutell, Associate Process Engineer in PAT | Novo Nordisk

Regulatory Focus by PEI
Oleg Krut, Head of Microbial Safety Department | Paul-Ehrlich-Institut (PEI)

Round Table
Moderator: A. Le Gatt
Participants: C. Cooke, F. Graf, O. Krut, M. Meinersmann, S. Strandberg Rutell, Johannes Oberdorfer | Rapid Micro Biosystems, Allison Scott | Member of Modern Microbial Methods (M3) Collaboration

 

SESSION 6 – KEY CONSIDERATIONS – Regulatory requirements for Alternative Methods: adoption & implementation

Focus on Ph. Eur. 5.1.6. commenting phase and USP <1071>, <72> and <73> updated release
Lucia Ceresa, Freelance Pharmaceutical Consultant & PDA Italy Chapter Board

Q&A Time
Lucia Ceresa, Freelance Pharmaceutical Consultant & PDA Italy Chapter Board

PharmaBiotech and Medical Device CompaniesRegulatory bodies and Technology Suppliers involved in the manufacturing and control of Sterile medicines.

Il corso si sviluppa attraverso lezioni frontali. Grazie ad una metodologia didattica interattiva con presentazione ed esempi pratici, i partecipanti potranno avere spunti da poter applicare nella loro realtà professionale.

Se il corso è online, il link di partecipazione verrà inviato 2-3 giorni prima dell’inizio del corso.

Sconto del 5% per le iscrizioni entro 1 mese dal corso, sconto del 10% per le iscrizioni entro 2 mesi dal corso. I prezzi sono da intendersi IVA esclusa. Le offerte non sono cumulabili. Per sconti su iscrizioni multiple rivolgersi a info@pharmaeducationcenter.it

Modalità di cancellazione

Si richiede di comunicare la disdetta all’evento formativo inviando un’e-mail a info@pharmaeducationcenter.it entro due settimane dalla data di inizio dello stesso. Trascorso tale termine, si procederà con l’addebito dell’intera quota.

Modalità di sostituzione partecipante

Si prevede la possibilità di cambiare il nome del partecipante all’evento formativo, senza alcun costo aggiuntivo, inviando un’e-mail a: info@pharmaeducationcenter.it. Si chiede di dare comunicazione entro una settimana dalla data di inizio dello stesso indicando il nome del primo iscritto e il nome del sostituto.

Condizioni di annullamento o rinvio

Pharma Education Center si riserva la facoltà di annullare o posticipare l’evento formativo nel caso in cui non si raggiunga un numero minimo di partecipanti. Pharma Education Center si impegna a restituire la quota d’iscrizione già versata senza ulteriori oneri o su richiesta dell’iscritto concedere un bonus spendibile per la partecipazione ad un altro evento formativo in programma nell’anno corrente.

Docenti

Lucia Ceresa

Lucia Ceresa

Freelance Pharmaceutical Consultant & PDA Italy Chapter Board

PDA Italy Chapter Board

Caitlin Cooke

Caitlin Cooke

Scientist, Global Product Development, Pharmaceutical Technology and Development

AstraZeneca

Franziska Graf

Franziska Graf

Trainee Microbiology and Monitoring Quality Control

Daiichi Sankyo Europe GmbH, Germany

Oleg Krut

Oleg Krut

Head of Microbial Safety Department

Paul-Ehrlich-Institut (PEI)

Alice Le Gatt

Alice Le Gatt

Global Change Facilitator

BioPhorum

Miriam Meinersmann

Miriam Meinersmann

Expert GMP Compliance and Documentation Microbiology and Monitoring Quality Control

Daiichi Sankyo Europe GmbH, Germany

Johannes Oberdorfer

Johannes Oberdorfer

Field Application Scientist

Rapid Micro Biosystems

Allison Scott

Allison Scott

Principal Scientist

BWT Pharma & Biotech Inc

Sebastian Strandberg Rutell

Sebastian Strandberg Rutell

Associate Process Engineer in PAT

Novo Nordisk

Iscriviti al corso

Early Bird 10%
Valido fino a 2 mesi dal corso
0€
300€
Early Bird 5%
Valido fino a 1 mese dal corso
0€
300€
Full price

300€

- +

Materiale del corso consegnato al partecipante

Rilascio attestato di partecipazione a fine corso

Massima qualità per contenuti e docenti selezionati

Potrebbe interessarti anche...

Richiedi informazioni